- Smilow Cancer Hospital Head and Neck Cancers ProgramSmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 4New Haven, CT 06511
- Smilow Cancer Hospital Head and Neck Cancers ProgramPark Avenue Medical Center5520 Park AvenueTrumbull, CT 06611
Saral Mehra, MD, MBA, FACS
Biography
Saral Mehra, MD, MBA, FACS, is a Yale Medicine surgeon who treats patients with head and neck cancers, sometimes performing complex microsurgeries that take many hours. When appropriate, he also uses the Da Vinci surgical robot and the laser to perform surgical tumor removal in hard-to-reach areas of the throat, with less morbidity than traditional approaches. In addition, he runs the salivary endoscopy program at Yale. Because of his widely recognized expertise, he treats patients with complex salivary disease who are sent to him from all over the state. Dr. Mehra provides minimally invasive treatment of salivary gland and duct problems, including salivary stones, using tiny scopes. He is able to perform these procedures without making any external incisions. “I use minimally invasive techniques for cancer and non-cancerous problems whenever possible, and I implement the latest in reconstructive surgery to optimize form and function,” he says.
Whatever problem he is treating, Dr. Mehra notes that be believes in spending time with patients to explain their condition and let them know that they are not alone is a key element in compassionate care. “When talking about a new diagnosis of cancer, I like to take the time to discuss the work-up, treatment, functional recovery and surveillance plan—this helps alleviate some of the fear of the unknown. It’s satisfying to look at the faces of a patient and their family when they go from being frightened of a new diagnosis to understanding the journey they are about to embark upon.”
Dr. Mehra says he enjoys being a physician for Yale Medicine because the practice has so many patients with complex head and neck tumors and patients who need reconstruction. “With high volume comes processes and systems that lead to better outcomes for patients,” he says.
He often works collaboratively as a member of a team that includes other surgeons, medical oncologists, radiation oncologists, pathologists and radiologists, as well as nurses, therapists, social workers and patient coordinators. “For patients who are to undergo surgery, the consultations, meetings and case review are all preparation for the big event—surgery—where, again, I put a team together to get the best patient outcomes,” he says.
Dr. Mehra is an Associate Professor of Surgery (Otolaryngology), and Chief of the Section of Head and Neck Surgery within the Division of Otolaryngology at Yale School of Medicine. He is also the Director of the Fellowship in Head and Neck Oncologic and Reconstructive Surgery, where he and his team of surgeons select one surgeon each year to train into their specialty, with trainees leading successful practices across the United States and world.
In addition to cancer and reconstructive surgery, he researches ways to improve the process of delivering cancer care. “This is important work, because we know that whenever we can improve upon the ways that we deliver cancer care, the better our outcomes will be,” he says.
Titles
- Associate Professor of Surgery (Otolaryngology)
- Section Chief, Head and Neck Surgery, Otolaryngology Surgery
- Director, Head and Neck Oncologic and Reconstructive Surgery Fellowship, Surgery
Education & Training
- FellowshipMount Sinai Beth Israel Medical Center (2013)
- ResidencyNew York Presbyterian Hospital (Columbia/Cornell) and Memorial Sloan Kettering Cancer Center (2012)
- InternshipNew York Presbyterian Hospital (Columbia/Cornell) (2008)
- MBAColumbia Business School (2007)
- MDColumbia Medical School (2007)
- BSQueen's University (2002)
Languages Spoken
- English
- Español (Spanish)
Additional Information
- Excellence in Clinical Care: Yale Cancer Center (2023)
- Faculty Teaching Award: Division of Otolaryngology (2022)
- Extra Mile Award: Department of Surgery (2020)
- Faculty Teaching Award: Division of Otolaryngology (2019)
- Chief Resident Teaching Award: Department of Otolaryngology (Columbia/Cornell) (2012)
- Distinguished House Staff Award: New York Presbyterian Hospital (2011)
- Coakley Memorial Prize for Excellence in Otolaryngology: Columbia University, College of Physicians and Surgeons (2007)
- Chancellor's Scholarship: Queen's University (1999)
- AB of Otolaryngology, Otolaryngology (2013)
- Shah H, Cohen O, Bourdillon A, Burtness B, Boffa D, Young M, Judson B, Mehra S. Identifying Opportunities to Deliver High‐Quality Cancer Care Across a Health System: A Clinical Responsibility. Otolaryngology 2024, 171: 445-456. PMID: 38606669, DOI: 10.1002/ohn.755.
- Cohen O, Brauer PR, Judson BL, Burtness BA, Earles J, Mehra S. Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival – A National study. Oral Oncology 2021, 125: 105694. PMID: 34971883, DOI: 10.1016/j.oraloncology.2021.105694.
- Jacobs D, Breen CT, Pucar D, Holt E, Judson BL, Mehra S. Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer. Thyroid 2020, 31: 272-279. PMID: 32811347, DOI: 10.1089/thy.2020.0237.
- Hanna J, Morse E, Brauer PR, Judson B, Mehra S. Positive margin rates and predictors in transoral robotic surgery after federal approval: A national quality study. Head & Neck 2019, 41: 3064-3072. PMID: 31058417, DOI: 10.1002/hed.25792.
- Li H, Torabi SJ, Park HS, Yarbrough WG, Mehra S, Choi R, Judson BL. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption. The Laryngoscope 2018, 129: 1844-1855. PMID: 30575965, DOI: 10.1002/lary.27740.
- Morse E, Henderson C, Carafeno T, Dibble J, Longley P, Chan E, Judson B, Yarbrough WG, Sasaki C, Mehra S. A Clinical Care Pathway to Reduce ICU Usage in Head and Neck Microvascular Reconstruction. Otolaryngology 2018, 160: 783-790. PMID: 30060705, DOI: 10.1177/0194599818782404.
- Morse E, Judson B, Husain Z, Burtness B, Yarbrough WG, Sasaki C, Cheraghlou S, Mehra S. Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival Associations. Otolaryngology 2018, 159: 987-997. PMID: 30060700, DOI: 10.1177/0194599818779052.
- Shah R, Wilkins S, Safranek C, Shah H, Brophy C, Mehra S. Detection, Patterns, and Outcomes of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngology - Head & Neck Surgery 2024, 150 PMID: 39418066, PMCID: PMC11581730, DOI: 10.1001/jamaoto.2024.3237.
- Dower J, MacLeod R, Cardoso B, Matouk C, Mehra S, Riccio G, Williams L, Majumdar S. 6645 Paraganglioma or Benign Ectopic Thyroid Tissue? Journal Of The Endocrine Society 2024, 8: bvae163.2032. PMCID: PMC11454000, DOI: 10.1210/jendso/bvae163.2032.
- Susan S, Gorman L, Santore E, Boldikova D, Ibrahim G, Kravchenko D, Khan M, Johnson D, Mehra S, Laskin W, Eskendri J. A Rare Pediatric Mandibular Mass: Diagnosis, Treatment and Reconstruction: A Case Report. Oral Surgery Oral Medicine Oral Pathology And Oral Radiology 2024, 138: e63. DOI: 10.1016/j.oooo.2024.04.096.
- Fereydooni S, Valdez C, William L, Malik D, Mehra S, Judson B. Predisposing, Enabling, and Need Factors Driving Palliative Care Use in Head and Neck Cancer. Otolaryngology 2024, 171: 1069-1082. PMID: 38796734, DOI: 10.1002/ohn.819.
- Mehra S. Re: “Prophylactic Intraoperative Antibiotic Dosing in Head and Neck Surgery: Opportunities for Improvement and Future Study”. Otolaryngology 2024, 171: 310-310. PMID: 38606625, DOI: 10.1002/ohn.768.
- Malik D, Jacobs D, Fereydooni S, Park H, Mehra S. Patterns of Care for T1 Glottic Squamous Cell Carcinomas from 2004–2020. The Laryngoscope 2024, 134: 3633-3644. PMID: 38411338, DOI: 10.1002/lary.31363.
- Filley G, Kayastha D, Hayes W, Mehra S, Sherman J, Eckelman M. Environmental Impact of a Direct Laryngoscopy: Opportunities for Pollution Mitigation. The Laryngoscope 2024, 134: 3206-3214. PMID: 38379176, DOI: 10.1002/lary.31341.
- Wilkins S, Shah R, Safranek C, Shah H, Mehra S. The Impact of Four Smoking Metrics on Survival After Diagnosis with HPV+ Oropharyngeal Cancer. The Laryngoscope 2024, 134: 3158-3164. PMID: 38294283, DOI: 10.1002/lary.31319.
- Safranek C, Wilkins S, Shah R, Mehra S. Automated AJCC Restaging for Oropharyngeal Cancer Research. Otolaryngology 2023, 170: 627-629. PMID: 37855637, DOI: 10.1002/ohn.558.
- Avery E, Joshi K, Mehra S, Mahajan A. Role of PET/CT in Oropharyngeal Cancers. Cancers 2023, 15: 2651. PMID: 37174116, PMCID: PMC10177278, DOI: 10.3390/cancers15092651.
- Shah H, Salehi P, Torabi S, Bourdillon A, Wu K, Mehra S. Trends in Private Equity Acquisitions of US Otolaryngology Practices. Otolaryngology 2023, 169: 1094-1097. PMID: 37003295, DOI: 10.1002/ohn.342.
- Salahuddin S, Cohen O, Wu M, Irizarry J, Vega T, Gan G, Deng Y, Isaeva N, Prasad M, Schalper K, Mehra S, Yarbrough W, Emu B. Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer. Clinical Infectious Diseases 2022, 76: 1449-1458. PMID: 36520995, PMCID: PMC10319962, DOI: 10.1093/cid/ciac924.
- Belzer A, Silber A, Mehra S, Gilani S, Leventhal JS. Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T‐DM1). British Journal Of Dermatology 2022, 187: e168-e168. PMID: 35633104, DOI: 10.1111/bjd.21654.
- Shah R, Cohen O, Panth N, Dibble J, Paolillo D, Cook A, Mehra S. Prophylactic Intraoperative Antibiotic Dosing in Head and Neck Surgery: Opportunities for Improvement and Future Study. Otolaryngology 2022, 169: 482-488. PMID: 36113029, DOI: 10.1177/01945998221126144.
- Salahuddin S, Cohen O, Wu M, Irizarry J, Vega T, Gan G, Deng Y, Isaeva N, Schalper K, Mehra S, Yarbrough W, Emu B. Impact of HIV infection on clinical outcomes among people diagnosed with head and neck cancer. Journal Of Clinical Oncology 2022, 40: e18080-e18080. DOI: 10.1200/jco.2022.40.16_suppl.e18080.
- Benchetrit L, Mehra S, Mahajan A, Rahmati RW, Judson BL, Edwards HA. Major Salivary Gland Cancer With Distant Metastasis Upon Presentation: Patterns, Outcomes, and Imaging Implications. Otolaryngology 2021, 167: 305-315. PMID: 34784258, DOI: 10.1177/01945998211058354.
- Yu J, Tsay C, Sasaki C, Son YH, Decker RH, Mehra S, Burtness B. Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs. Oral Oncology 2021, 122: 105585. PMID: 34688055, DOI: 10.1016/j.oraloncology.2021.105585.
- Cohen O, Morse E, Fujiwara RJT, Dibble J, Pierce M, Mehra S. The impact of a double vein anastomoses on doppler's loss of signal rates. European Journal Of Surgical Oncology 2021, 48: 27-31. PMID: 34610861, DOI: 10.1016/j.ejso.2021.09.021.
- Breen CT, Chao J, Mehra S, Kohli N. Extranodal Head and Neck Mantle Cell Lymphoma: Characteristics, Treatment, and Survival. Annals Of Otology Rhinology & Laryngology 2021, 131: 412-419. PMID: 34137303, DOI: 10.1177/00034894211025171.
- Torabi SJ, Kasle DA, Su-Velez B, Mehra S, Day TA, Yarbrough WG, St. John M, Judson BL. A 2020 Update on Public Awareness of Head and Neck Cancers. Otolaryngology 2021, 166: 305-312. PMID: 33845657, DOI: 10.1177/01945998211006932.
- Bourdillon AT, Mehra S, Rahmati R, Judson B, Edwards HA. Anesthesia screen use may impact operating room communication practices in otolaryngology. American Journal Of Otolaryngology 2021, 42: 103000. PMID: 33812208, DOI: 10.1016/j.amjoto.2021.103000.
- Bellamkonda KS, Fereydooni A, Trott K, Lee Y, Mehra S, Nassiri N. Superselective intranidal delivery of platinum-based high-density packing coils for treatment of arteriovenous malformations. Journal Of Vascular Surgery Cases And Innovative Techniques 2021, 7: 230-234. PMID: 33997560, PMCID: PMC8095044, DOI: 10.1016/j.jvscit.2021.01.005.
- Jacobs D, Kafle S, Earles J, Rahmati R, Mehra S, Judson BL. Prolonged inpatient stay after upfront total laryngectomy is associated with overall survival. Laryngoscope Investigative Otolaryngology 2021, 6: 94-102. PMID: 33614936, PMCID: PMC7883619, DOI: 10.1002/lio2.441.
- Izreig S, Alzahrani F, Earles J, Mehra S, Judson BL, Pan Z, Rahmati RW. Hyperprogression of a Sinonasal Squamous Cell Carcinoma Following Programmed Cell Death Protein-1 Checkpoint Blockade. JAMA Otolaryngology - Head & Neck Surgery 2020, 146: 1176-1178. PMID: 32940637, DOI: 10.1001/jamaoto.2020.2584.
- Jacobs D, Torabi SJ, Park HS, Rahmati R, Young MR, Mehra S, Judson BL. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer. Otolaryngology 2020, 164: 1240-1248. PMID: 33198564, DOI: 10.1177/0194599820969613.
- Izreig S, Hajek M, Edwards HA, Mehra S, Sasaki C, Judson BL, Rahmati RW. The role of vitamin D in head and neck cancer. Laryngoscope Investigative Otolaryngology 2020, 5: 1079-1088. PMID: 33364397, PMCID: PMC7752058, DOI: 10.1002/lio2.469.
- JIANG R, MARQUEZ J, TOWER JI, JACOBS D, CHEN W, MEHRA S, PRASAD ML, JUDSON BL. Sequencing of Sclerosing Microcystic Adenocarcinoma Identifies Mutational Burden and Somatic Variants Associated With Tumorigenesis. Anticancer Research 2020, 40: 6375-6379. PMID: 33109575, DOI: 10.21873/anticanres.14658.
- Morse E, Salehi PP, Mehra S. Re: “Value of Intensive Care Unit-Based Postoperative Management for Microvascular Free Flap Reconstruction in Head and Neck Surgery” by Yalamanchi et al. Facial Plastic Surgery & Aesthetic Medicine 2020, 23: 151-151. PMID: 32845717, DOI: 10.1089/fpsam.2020.0403.
- Torabi SJ, Bourdillon A, Salehi PP, Kafle S, Mehra S, Rahmati R, Judson BL. The epidemiology, surgical management, and impact of margins in skull and mandibular osseous‐site tumors. Head & Neck 2020, 42: 3352-3363. PMID: 32743892, DOI: 10.1002/hed.26389.
- Breen CT, Mehra S. An Analysis of Otolaryngology Medical Malpractice Payments From the National Practitioner Data Bank. Otolaryngology 2020, 164: 589-594. PMID: 32691675, DOI: 10.1177/0194599820942498.
- Jacobs D, Torabi SJ, Gibson C, Rahmati R, Mehra S, Judson BL. Assessing National Utilization Trends and Outcomes of Robotic and Endoscopic Thyroidectomy in the United States. Otolaryngology 2020, 163: 947-955. PMID: 32539533, DOI: 10.1177/0194599820927699.
- Jacobs D, Park H, Young M, Olino K, Rahmati R, Mehra S, Burtness B, Judson B. Assessment of Lymph Node Evaluation in Patients with Clinically Node Negative Merkel Cell Carcinoma of the Head and Neck. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1191-1192. DOI: 10.1016/j.ijrobp.2019.11.099.
- Jacobs D, Park H, Young M, Breen C, Rahmati R, Mehra S, Judson B. An Update on Trends and Disparities in Utilization of Total Laryngectomy: a Population-Based Analysis. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1145-1146. DOI: 10.1016/j.ijrobp.2019.11.214.
- Jacobs D, Park H, Rahmati R, Mehra S, Judson B. Changing Demographics of Laryngeal Cancer: Are Patients Getting Younger? International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1162-1163. DOI: 10.1016/j.ijrobp.2019.11.186.
- Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancerSaeed NA, Kelly JR, Deshpande HA, Bhatia AK, Burtness BA, Judson BL, Mehra S, Edwards HA, Yarbrough WG, Peter PR, Holt EH, Decker RH, Husain ZA, Park HS. Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer. Head & Neck 2020, 42: 1031-1044. PMID: 32011055, DOI: 10.1002/hed.26086.
- Yu J, Tsay C, Sasaki C, Son Y, Decker R, Mehra S, Burtness B. 1127P Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs. Annals Of Oncology 2019, 30: v457. DOI: 10.1093/annonc/mdz252.019.
- Husain Z, Lee N, Eskander A, Park H, mehra S, Burtness B. 1149P Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment. Annals Of Oncology 2019, 30: v466. DOI: 10.1093/annonc/mdz252.041.
- Morse E, Hanna J, Mehra S. The Association between Industry Payments and Brand‐Name Prescriptions in Otolaryngologists. Otolaryngology 2019, 161: 605-612. PMID: 31547772, DOI: 10.1177/0194599819852321.
- Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant TherapyLOGANADANE G, KANN BH, PARK HS, JOHNSON SB, MEHRA S, JUDSON BL, BHATIA A, BELKACEMI Y, YARBROUGH WG, BURTNESS B, HUSAIN ZA. Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy. Anticancer Research 2019, 39: 4885-4890. PMID: 31519591, DOI: 10.21873/anticanres.13674.
- Hanna J, Brauer PR, Morse E, Mehra S. Margins in Laryngeal Squamous Cell Carcinoma Treated with Transoral Laser Microsurgery: A National Database Study. Otolaryngology 2019, 161: 986-992. PMID: 31476984, DOI: 10.1177/0194599819874315.
- Clinical Outcomes of Head and Neck Cancer Patients who Undergo Resection, but Forgo Adjuvant TherapyLoganadane G, Kann B, Park H, Johnson S, Mehra S, Judson B, Bhatia A, Belkacemi Y, Yarbrough W, Burtness B, Husain Z. Clinical Outcomes of Head and Neck Cancer Patients who Undergo Resection, but Forgo Adjuvant Therapy. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e375-e376. DOI: 10.1016/j.ijrobp.2019.06.1628.
- Benchetrit L, Torabi SJ, Morse E, Mehra S, Rahmati R, Osborn HA, Judson BL. Preoperative biopsy in parotid malignancies: Variation in use and impact on surgical margins. The Laryngoscope 2019, 130: 1450-1458. PMID: 31411749, DOI: 10.1002/lary.28224.
- Hanna J, Brauer PR, Morse E, Berson E, Mehra S. Epidemiological analysis of croup in the emergency department using two national datasets. International Journal Of Pediatric Otorhinolaryngology 2019, 126: 109641. PMID: 31442871, DOI: 10.1016/j.ijporl.2019.109641.
- Hanna J, Brauer PR, Morse E, Judson B, Mehra S. Is robotic surgery an option for early T‐stage laryngeal cancer? Early nationwide results. The Laryngoscope 2019, 130: 1195-1201. PMID: 31233223, DOI: 10.1002/lary.28144.
- Benchetrit L, Morse E, Judson BL, Mehra S. Positive Surgical Margins in Submandibular Malignancies: Facility and Practice Variation. Otolaryngology 2019, 161: 620-628. PMID: 31159649, DOI: 10.1177/0194599819852094.
- Lee NCJ, Eskander A, Park HS, Mehra S, Burtness BA, Husain Z. Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment. Cancer 2019, 125: 2975-2983. PMID: 31090934, DOI: 10.1002/cncr.32161.
- Benchetrit L, Torabi SJ, Tate JP, Mehra S, Osborn HA, Young MR, Burtness B, Judson BL. Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment. Oral Oncology 2019, 94: 32-40. PMID: 31178210, DOI: 10.1016/j.oraloncology.2019.05.009.
- Brauer PR, Morse E, Mehra S. Industry Payments for Otolaryngology Research: A Four‐Year Analysis of the Open Payments Database. The Laryngoscope 2019, 130: 314-320. PMID: 31059584, DOI: 10.1002/lary.27896.
- Miccio J, Kelly J, Kann B, An Y, Park H, Verma V, Mehra S, Judson B, Burtness B, Husain Z. OA01 Impact of Contralateral Lymph Node Involvement on Survival of Surgically-Managed HPV-Positive Oropharyngeal Cancer Staged with the AJCC Eighth Edition. International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e1. DOI: 10.1016/s0360-3016(19)30402-x.
- Morse E, Berson E, Mehra S. Industry Involvement in Otolaryngology: Updates from the 2017 Open Payments Database. Otolaryngology 2019, 161: 265-270. PMID: 30909808, DOI: 10.1177/0194599819838268.
- Hanna J, Brauer PR, Berson E, Mehra S. Adult epiglottitis: Trends and predictors of mortality in over 30 thousand cases from 2007 to 2014. The Laryngoscope 2018, 129: 1107-1112. PMID: 30582183, DOI: 10.1002/lary.27741.
- Mehra S, Fujiwara R. In Response to Accuracy and Reliability of the Flow Coupler in Postoperative Monitoring of Head and Neck Free Flaps. The Laryngoscope 2018, 129: e8-e8. PMID: 30499110, DOI: 10.1002/lary.27332.
- Savoca E, Mehra S, Waldman EH. A case of pediatric cervicofacial actinomyces masquerading as malignancy: Case report and review of the literature. International Journal Of Pediatric Otorhinolaryngology 2018, 116: 204-208. PMID: 30554700, DOI: 10.1016/j.ijporl.2018.11.001.
- Morse E, Berson E, Fujiwara R, Judson B, Mehra S. Hypopharyngeal Cancer Treatment Delays: Benchmarks and Survival Association. Otolaryngology 2018, 160: 267-276. PMID: 30324861, DOI: 10.1177/0194599818797605.
- Morse E, Fujiwara RJT, Mehra S. Industry Payments to Physicians and Prescriptions of Brand‐Name Proton‐Pump Inhibitors. Otolaryngology 2018, 160: 70-76. PMID: 30325706, DOI: 10.1177/0194599818803337.
- Delgado S, Smith SM, Mehra S, Prasad ML. Composite Paraganglioma: Pioneering in the Head and Neck. International Journal Of Surgical Pathology 2018, 27: 282-289. PMID: 30222023, DOI: 10.1177/1066896918799940.
- Morse E, Fujiwara RJT, Judson B, Prasad ML, Mehra S. Positive surgical margins in parotid malignancies: Institutional variation and survival association. The Laryngoscope 2018, 129: 129-137. PMID: 30194762, DOI: 10.1002/lary.27221.
- Cheraghlou S, Schettino A, Zogg CK, Otremba MD, Bhatia A, Park HS, Osborn HA, Mehra S, Yarbrough WG, Judson BL. Adjuvant Chemotherapy Is Associated With Improved Survival for Late‐Stage Salivary Squamous Cell Carcinoma. The Laryngoscope 2018, 129: 883-889. PMID: 30151947, DOI: 10.1002/lary.27444.
- Cheraghlou S, Torabi SJ, Husain ZA, Otremba MD, Osborn HA, Mehra S, Yarbrough WG, Burtness BA, Judson BL. HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes. The Laryngoscope 2018, 129: 684-691. PMID: 30151832, DOI: 10.1002/lary.27475.
- Cheraghlou S, Yu PK, Otremba MD, Mehra S, Yarbrough WG, Judson BL. Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glands. Cancers Of The Head & Neck 2018, 3: 5. PMID: 31093358, PMCID: PMC6460801, DOI: 10.1186/s41199-018-0032-x.
- Morse E, Fujiwara RJT, Mehra S. The Association of Industry Payments to Physicians with Prescription of Brand‐Name Intranasal Corticosteroids. Otolaryngology 2018, 159: 442-448. PMID: 29865931, DOI: 10.1177/0194599818774739.
- Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall SurvivalLi H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. JAMA Otolaryngology - Head & Neck Surgery 2018, 144: 519-525. PMID: 29801040, PMCID: PMC6583856, DOI: 10.1001/jamaoto.2018.0395.
- Morse E, Fujiwara RJT, Mehra S. Increasing Industry Involvement in Otolaryngology: Insights from 3 Years of the Open Payments Database. Otolaryngology 2018, 159: 501-507. PMID: 29807484, DOI: 10.1177/0194599818778502.
- Morse E, Judson B, Husain Z, Burtness B, Yarbrough W, Sasaki C, Cheraghlou S, Mehra S. National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiation. Oral Oncology 2018, 82: 122-130. PMID: 29909886, DOI: 10.1016/j.oraloncology.2018.02.010.
- Morse E, Fujiwara RJT, Judson B, Mehra S. Treatment delays in laryngeal squamous cell carcinoma: A national cancer database analysis. The Laryngoscope 2018, 128: 2751-2758. PMID: 29756382, DOI: 10.1002/lary.27247.
- Cheraghlou S, Kuo P, Mehra S, Agogo GO, Bhatia A, Husain ZA, Yarbrough WG, Burtness BA, Judson BL. Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database. Head & Neck 2018, 40: 1343-1355. PMID: 29756412, DOI: 10.1002/hed.24984.
- Morse E, Fujiwara RJT, Husain Z, Judson B, Mehra S. Pediatric Salivary Cancer: Epidemiology, Treatment Trends, and Association of Treatment Modality with Survival. Otolaryngology 2018, 159: 553-563. PMID: 29688836, DOI: 10.1177/0194599818771926.
- Kelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer. Oral Oncology 2018, 79: 64-70. PMID: 29598952, DOI: 10.1016/j.oraloncology.2018.02.017.
- Morse E, Fujiwara RJT, Judson B, Mehra S. Treatment Times in Salivary Gland Cancer: National Patterns and Association with Survival. Otolaryngology 2018, 159: 283-292. PMID: 29460669, DOI: 10.1177/0194599818758020.
- Pathak N, Fujiwara RJT, Mehra S. Assessment of Nonresearch Industry Payments to Otolaryngologists in 2014 and 2015. Otolaryngology 2018, 158: 1028-1034. PMID: 29437524, DOI: 10.1177/0194599818758661.
- Cheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL. Salvage Surgery after Radiation Failure in T1/T2 Larynx Cancer: Outcomes following Total versus Conservation Surgery. Otolaryngology 2018, 158: 497-504. PMID: 29292665, DOI: 10.1177/0194599817742596.
- Cheraghlou S, Yu PK, Otremba MD, Park HS, Bhatia A, Zogg CK, Mehra S, Yarbrough WG, Judson BL. Treatment deintensification in human papillomavirus‐positive oropharynx cancer: Outcomes from the National Cancer Data Base. Cancer 2017, 124: 717-726. PMID: 29243245, DOI: 10.1002/cncr.31104.
- Biktasova A, Hajek M, Sewell A, Gary C, Bellinger G, Deshpande HA, Bhatia A, Burtness B, Judson B, Mehra S, Yarbrough WG, Issaeva N. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus–Associated Head and Neck Cancer. Clinical Cancer Research 2017, 23: 7276-7287. PMID: 28916527, DOI: 10.1158/1078-0432.ccr-17-1438.
- Outcomes and reliability of the flow coupler in postoperative monitoring of head and neck free flapsFujiwara RJT, Dibble JM, Larson SV, Pierce ML, Mehra S. Outcomes and reliability of the flow coupler in postoperative monitoring of head and neck free flaps. The Laryngoscope 2017, 128: 812-817. PMID: 28988465, DOI: 10.1002/lary.26944.
- Fujiwara RJT, Shih AF, Mehra S. Cross‐sectional Analysis of the Relationship between Paranasal Sinus Balloon Catheter Dilations and Industry Payments among Otolaryngologists. Otolaryngology 2017, 157: 880-886. PMID: 28895455, DOI: 10.1177/0194599817728897.
- Cheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL. Untreated oral cavity cancer: Long‐term survival and factors associated with treatment refusal. The Laryngoscope 2017, 128: 664-669. PMID: 28865100, DOI: 10.1002/lary.26809.
- Fujiwara RJT, Burtness B, Husain ZA, Judson BL, Bhatia A, Sasaki CT, Yarbrough WG, Mehra S. Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatment. Oral Oncology 2017, 71: 129-137. PMID: 28688680, DOI: 10.1016/j.oraloncology.2017.06.013.
- Husain ZA, Chen T, Corso CD, Wang Z, Park H, Judson B, Yarbrough W, Deshpande H, Mehra S, Kuo P, Decker RH, Burtness BA. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma. JAMA Oncology 2017, 3: 358-365. PMID: 27737449, DOI: 10.1001/jamaoncol.2016.4581.
- Fujiwara RJ, Judson BL, Yarbrough WG, Husain Z, Mehra S. Treatment delays in oral cavity squamous cell carcinoma and association with survival. Head & Neck 2017, 39: 639-646. PMID: 28236349, DOI: 10.1002/hed.24608.
- Kuo P, Mehra S, Sosa JA, Roman SA, Husain ZA, Burtness BA, Tate JP, Yarbrough WG, Judson BL. Proposing prognostic thresholds for lymph node yield in clinically lymph node‐negative and lymph node‐positive cancers of the oral cavity. Cancer 2016, 122: 3624-3631. PMID: 27479645, DOI: 10.1002/cncr.30227.
- Subramanian HE, Park HS, Barbieri A, Mahajan A, Judson BL, Mehra S, Yarbrough WG, Burtness BA, Husain ZA. Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study. Cancers Of The Head & Neck 2016, 1: 7. PMID: 31093337, PMCID: PMC6460847, DOI: 10.1186/s41199-016-0008-7.
- Panaccione A, Chang MT, Carbone BE, Guo Y, Moskaluk CA, Virk RK, Chiriboga L, Prasad ML, Judson B, Mehra S, Yarbrough WG, Ivanov SV. NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic Carcinoma. Clinical Cancer Research 2016, 22: 2083-2095. PMID: 27084744, PMCID: PMC4834904, DOI: 10.1158/1078-0432.ccr-15-2208.
- Kuo P, Sosa JA, Burtness BA, Husain ZA, Mehra S, Roman SA, Yarbrough WG, Judson BL. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base. Cancer 2016, 122: 1853-1860. PMID: 27019213, DOI: 10.1002/cncr.29962.
- Haser GC, Tuttle RM, Su HK, Alon EE, Bergman D, Bernet V, Brett E, Cobin R, Dewey EH, Doherty G, Dos Reis LL, Harris J, Klopper J, Lee SL, Levine RA, Lepore SJ, Likhterov I, Lupo MA, Machac J, Mechanick JI, Mehra S, Milas M, Orloff LA, Randolph G, Revenson TA, Roberts KJ, Ross DS, Rowe ME, Smallridge RC, Terris D, Tufano RP, Urken ML. Active Surveillance for Papillary Thyroid Microcarcinoma: New Challenges and Opportunities for The Health Care System. Endocrine Practice 2016, 22: 602-611. PMID: 26799628, PMCID: PMC5539410, DOI: 10.4158/ep151065.ra.
- Rowe ME, Clain JB, Scherl S, Dos Reis L, Turk A, Wenig BM, Mehra S, Urken ML. Response to “Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology”. European Journal Of Surgical Oncology 2015, 42: 156-157. PMID: 26632081, DOI: 10.1016/j.ejso.2015.09.029.
- Castro J, Likhterov I, Mehra S, Bassiri-Tehrani M, Scherl S, Clain J, Buchbinder D, Urken ML. Approach to en bloc resection and reconstruction of primary masticator space malignancies. The Laryngoscope 2015, 126: 372-377. PMID: 26526821, DOI: 10.1002/lary.25500.
- Schwam ZG, Burtness B, Yarbrough WG, Mehra S, Husain Z, Judson BL. National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database. Cancer Medicine 2015, 4: 1828-1835. PMID: 26471244, PMCID: PMC5123708, DOI: 10.1002/cam4.546.
- Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Hospital readmission and 30‐day mortality after surgery for oral cavity cancer: Analysis of 21,681 cases. Head & Neck 2015, 38: e221-e226. PMID: 25537226, DOI: 10.1002/hed.23973.
- Azar M, Folk D, Henderson T, Mehra S, Vining E, Banach D. Cervicofacial necrotizing fasciitis caused by Haemophilus influenzae serotype e in a patient with Sjogren's syndrome, systemic lupus erythematosus and hypocomplementaemia. JMM Case Reports 2015, 2 DOI: 10.1099/jmmcr.0.000040.
- Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base. JAMA Otolaryngology - Head & Neck Surgery 2015, 141: 593-598. PMID: 25974757, DOI: 10.1001/jamaoto.2015.0719.
- Rathi VK, Ross JS, Samuel AM, Mehra S. Postmarket Modifications of High‐Risk Therapeutic Devices in Otolaryngology Cleared by the US Food and Drug Administration. Otolaryngology 2015, 153: 400-408. PMID: 26044785, DOI: 10.1177/0194599815587508.
- Tewari A, Blumberg J, Mehra S. An Infratemporal Fossa Mass. JAMA Otolaryngology - Head & Neck Surgery 2015, 141: 575-576. PMID: 25880880, DOI: 10.1001/jamaoto.2015.0517.
- Temporoparietal fascia flap “sandwich” technique for repair of near‐total traumatic auricle avulsionKong DK, Schutt CA, Mehra S. Temporoparietal fascia flap “sandwich” technique for repair of near‐total traumatic auricle avulsion. The Laryngoscope 2015, 126: 826-828. PMID: 26014884, DOI: 10.1002/lary.25394.
- Rathi VK, Samuel AM, Mehra S. Industry Ties in Otolaryngology. Otolaryngology 2015, 152: 993-999. PMID: 25779469, DOI: 10.1177/0194599815573718.
- Mehra S, Tuttle RM, Milas M, Orloff L, Bergman D, Bernet V, Brett E, Cobin R, Doherty G, Judson BL, Klopper J, Lee S, Lupo M, Machac J, Mechanick JI, Randolph G, Ross DS, Smallridge R, Terris D, Tufano R, Alon E, Clain J, DosReis L, Scherl S, Urken ML. Database and Registry Research in Thyroid Cancer: Striving for a New and Improved National Thyroid Cancer Database. Thyroid 2015, 25: 157-168. PMID: 25517683, DOI: 10.1089/thy.2014.0270.
- Mehra S, Jacobson A, Urken M. Free Tissue for Reconstruction of the Bony Facial Skeleton. 2014, 633-670. DOI: 10.1201/b17991-35.
- Scherl S, Mehra S, Clain J, Dos Reis L, Persky M, Turk A, Weing B, Husaini H, Urken M. The Effect of Surgeon Experience on the Detection of Metastatic Lymph Nodes in the Central Compartment and the Pathologic Features of Clinically Unapparent Metastatic Lymph Nodes: What Are We Missing When We Don't Perform a Prophylactic Dissection of Central Compartment Lymph Nodes in Papillary Thyroid Cancer? VideoEndocrinology 2014, 1 DOI: 10.1089/ve.2014.0022.
- Clain JB, Mehra S, Scherl S, Dos Reis LL, Turk A, Wenig BM, Dewey EH, Urken ML. Intrathyroidal Tumors Presenting with Extranodal Extension: What Are We Missing? Endocrine Pathology 2014, 25: 385-389. PMID: 25325929, DOI: 10.1007/s12022-014-9340-9.
- Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Positive Surgical Margins in Early Stage Oral Cavity Cancer: An Analysis of 20,602 Cases. Otolaryngology 2014, 151: 984-990. PMID: 25257901, DOI: 10.1177/0194599814551718.
- Dos Reis LL, Tuttle RM, Alon E, Bergman DA, Bernet V, Brett EM, Cobin R, Doherty G, Harris JR, Klopper J, Lee SL, Lupo M, Milas M, Machac J, Mechanick JI, Orloff L, Randolph G, Ross DS, Smallridge RC, Terris DJ, Tufano RP, Mehra S, Scherl S, Clain JB, Urken ML. What Is the Gold Standard for Comprehensive Interinstitutional Communication of Perioperative Information for Thyroid Cancer Patients? A Comparison of Existing Electronic Health Records with the Current American Thyroid Association Recommendations. Thyroid 2014, 24: 1466-1472. PMID: 25036190, DOI: 10.1089/thy.2014.0209.
- Aronberg RM, Punekar SR, Adam SI, Judson BL, Mehra S, Yarbrough WG. Esophageal perforation caused by edible foreign bodies: A systematic review of the literature. The Laryngoscope 2014, 125: 371-378. PMID: 25155167, DOI: 10.1002/lary.24899.
- Dos Reis LL, Mehra S, Scherl S, Clain J, Machac J, Urken ML. The Differential Diagnosis of Central Compartment Radioactive Iodine Uptake After Thyroidectomy: Anatomic and Surgical Considerations. Endocrine Practice 2014, 20: 832-838. PMID: 24793917, DOI: 10.4158/ep13435.ra.
- Gibber MJ, Clain JB, Jacobson AS, Buchbinder D, Scherl S, Zevallos JP, Mehra S, Urken ML. Subscapular system of flaps: An 8‐year experience with 105 patients. Head & Neck 2014, 37: 1200-1206. PMID: 24800735, DOI: 10.1002/hed.23738.
- Dibelius G, Mehra S, Clain JB, Urken ML, Wenig BM. Noninvasive Anaplastic Thyroid Carcinoma: Report of a Case and Literature Review. Thyroid 2014, 24: 1319-1324. PMID: 24865498, DOI: 10.1089/thy.2013.0586.
- Scherl S, Mehra S, Clain J, Dos Reis LL, Persky M, Turk A, Wenig B, Husaini H, Urken ML. The Effect of Surgeon Experience on the Detection of Metastatic Lymph Nodes in the Central Compartment and the Pathologic Features of Clinically Unapparent Metastatic Lymph Nodes: What Are We Missing When We Don't Perform a Prophylactic Dissection of Central Compartment Lymph Nodes in Papillary Thyroid Cancer? Thyroid 2014, 24: 1282-1288. PMID: 24787362, DOI: 10.1089/thy.2013.0600.
- Clain JB, Scherl S, Dos Reis L, Turk A, Wenig BM, Mehra S, Karle WE, Urken ML. Extrathyroidal Extension Predicts Extranodal Extension in Patients with Positive Lymph Nodes: An Important Association That May Affect Clinical Management. Thyroid 2014, 24: 951-957. PMID: 24443878, DOI: 10.1089/thy.2013.0557.
- Mehra S, Scherl S, Lazarus C, Dewey E, Urken ML. Transtracheal approach to repair of a tracheo‐colonic fistula 44 years after colonic interposition. Head & Neck 2014, 36: e117-e120. PMID: 24375707, DOI: 10.1002/hed.23586.
- Mehra S, Tuttle RM, Bergman D, Bernet V, Brett E, Cobin R, Doherty G, Klopper J, Lee S, Machac J, Milas M, Mechanick JI, Orloff L, Randolph G, Ross DS, Smallridge R, Terris D, Tufano R, Alon E, Clain J, Dos Reis L, Scherl S, Urken ML. Improving the Quality of Thyroid Cancer Care: How Does the Thyroid Cancer Care Collaborative Cross the Institute of Medicine's Quality Chasm? Thyroid 2014, 24: 615-624. PMID: 24512449, DOI: 10.1089/thy.2013.0441.
- Mehra S, Heineman TE, Cammisa FP, Girardi FP, Sama AA, Kutler DI. Factors Predictive of Voice and Swallowing Outcomes after Anterior Approaches to the Cervical Spine. Otolaryngology 2013, 150: 259-265. PMID: 24367048, DOI: 10.1177/0194599813515414.
- Mehra S, Liu J, Gupta A, Sheinfeld J, Kraus D. Cervical metastasis of germ cell tumors: Evaluation, management, complications, and outcomes. The Laryngoscope 2012, 122: 286-290. PMID: 22252920, DOI: 10.1002/lary.22422.
- Morris LG, Mehra S, Shah JP, Bilsky MH, Selesnick SH, Kraus DH. Predictors of survival and recurrence after temporal bone resection for cancer. Head & Neck 2011, 34: 1231-1239. PMID: 21953902, PMCID: PMC4126564, DOI: 10.1002/hed.21883.
- Mehra S, Morris L, Shah J, Bilsky M, Selesnick S, Kraus D. Outcomes of Temporal Bone Resection for Locally Advanced Parotid Cancer. Journal Of Neurological Surgery Part B Skull Base 2011, 21: 389-396. PMID: 22547966, PMCID: PMC3312127, DOI: 10.1055/s-0031-1287682.
- Mehra S, Chang C, Kacker A. Isolated Sarcoidosis of the Tonsil: Case Report and Literature Review. The Laryngoscope 2011, 121: s79-s79. DOI: 10.1002/lary.21949.
- Mehra S, Morris L, Shah J, Bilsky M, Selesnick S, Kraus D. Outcomes of Temporal Bone Resection for Locally Advanced Parotid Cancer. Journal Of Neurological Surgery Part B Skull Base 2011, 21 DOI: 10.1055/s-2011-1274336.
- Morris L, Mehra S, Shah J, Bilsky M, Selesnick S, Kraus D. Predictors of Survival and Recurrence after Temporal Bone Resection for Cancer. Journal Of Neurological Surgery Part B Skull Base 2011, 21 DOI: 10.1055/s-2011-1274337.
- Nyquist GG, Anand VK, Mehra S, Kacker A, Schwartz TH. Endoscopic endonasal repair of anterior skull base non-traumatic cerebrospinal fluid leaks, meningoceles, and encephaloceles. Journal Of Neurosurgery 2009, 113: 961-6. PMID: 19929192, DOI: 10.3171/2009.10.jns08986.
- Nyquist G, Anand V, Mehra S, Kacker A, Schwartz T. Endoscopic Endonasal Repair of Anterior Skull Base Encephaloceles and Cerebrospinal Fluid Leaks. Journal Of Neurological Surgery Part B Skull Base 2009, 19 DOI: 10.1055/s-2009-1242328.
- Mehra S, Eavey RD, Keamy DG. The epidemiology of hearing impairment in the United States: Newborns, children, and adolescents. Otolaryngology 2009, 140: 461-472. PMID: 19328331, DOI: 10.1016/j.otohns.2008.12.022.
- Smilow Cancer Hospital Head and Neck Cancers ProgramSmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 4New Haven, CT 06511
- Smilow Cancer Hospital Head and Neck Cancers ProgramPark Avenue Medical Center5520 Park AvenueTrumbull, CT 06611
Biography
Saral Mehra, MD, MBA, FACS, is a Yale Medicine surgeon who treats patients with head and neck cancers, sometimes performing complex microsurgeries that take many hours. When appropriate, he also uses the Da Vinci surgical robot and the laser to perform surgical tumor removal in hard-to-reach areas of the throat, with less morbidity than traditional approaches. In addition, he runs the salivary endoscopy program at Yale. Because of his widely recognized expertise, he treats patients with complex salivary disease who are sent to him from all over the state. Dr. Mehra provides minimally invasive treatment of salivary gland and duct problems, including salivary stones, using tiny scopes. He is able to perform these procedures without making any external incisions. “I use minimally invasive techniques for cancer and non-cancerous problems whenever possible, and I implement the latest in reconstructive surgery to optimize form and function,” he says.
Whatever problem he is treating, Dr. Mehra notes that be believes in spending time with patients to explain their condition and let them know that they are not alone is a key element in compassionate care. “When talking about a new diagnosis of cancer, I like to take the time to discuss the work-up, treatment, functional recovery and surveillance plan—this helps alleviate some of the fear of the unknown. It’s satisfying to look at the faces of a patient and their family when they go from being frightened of a new diagnosis to understanding the journey they are about to embark upon.”
Dr. Mehra says he enjoys being a physician for Yale Medicine because the practice has so many patients with complex head and neck tumors and patients who need reconstruction. “With high volume comes processes and systems that lead to better outcomes for patients,” he says.
He often works collaboratively as a member of a team that includes other surgeons, medical oncologists, radiation oncologists, pathologists and radiologists, as well as nurses, therapists, social workers and patient coordinators. “For patients who are to undergo surgery, the consultations, meetings and case review are all preparation for the big event—surgery—where, again, I put a team together to get the best patient outcomes,” he says.
Dr. Mehra is an Associate Professor of Surgery (Otolaryngology), and Chief of the Section of Head and Neck Surgery within the Division of Otolaryngology at Yale School of Medicine. He is also the Director of the Fellowship in Head and Neck Oncologic and Reconstructive Surgery, where he and his team of surgeons select one surgeon each year to train into their specialty, with trainees leading successful practices across the United States and world.
In addition to cancer and reconstructive surgery, he researches ways to improve the process of delivering cancer care. “This is important work, because we know that whenever we can improve upon the ways that we deliver cancer care, the better our outcomes will be,” he says.
Titles
- Associate Professor of Surgery (Otolaryngology)
- Section Chief, Head and Neck Surgery, Otolaryngology Surgery
- Director, Head and Neck Oncologic and Reconstructive Surgery Fellowship, Surgery
Education & Training
- FellowshipMount Sinai Beth Israel Medical Center (2013)
- ResidencyNew York Presbyterian Hospital (Columbia/Cornell) and Memorial Sloan Kettering Cancer Center (2012)
- InternshipNew York Presbyterian Hospital (Columbia/Cornell) (2008)
- MBAColumbia Business School (2007)
- MDColumbia Medical School (2007)
- BSQueen's University (2002)
Languages Spoken
- English
- Español (Spanish)
Additional Information
- Excellence in Clinical Care: Yale Cancer Center (2023)
- Faculty Teaching Award: Division of Otolaryngology (2022)
- Extra Mile Award: Department of Surgery (2020)
- Faculty Teaching Award: Division of Otolaryngology (2019)
- Chief Resident Teaching Award: Department of Otolaryngology (Columbia/Cornell) (2012)
- Distinguished House Staff Award: New York Presbyterian Hospital (2011)
- Coakley Memorial Prize for Excellence in Otolaryngology: Columbia University, College of Physicians and Surgeons (2007)
- Chancellor's Scholarship: Queen's University (1999)
- AB of Otolaryngology, Otolaryngology (2013)
- Shah H, Cohen O, Bourdillon A, Burtness B, Boffa D, Young M, Judson B, Mehra S. Identifying Opportunities to Deliver High‐Quality Cancer Care Across a Health System: A Clinical Responsibility. Otolaryngology 2024, 171: 445-456. PMID: 38606669, DOI: 10.1002/ohn.755.
- Cohen O, Brauer PR, Judson BL, Burtness BA, Earles J, Mehra S. Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival – A National study. Oral Oncology 2021, 125: 105694. PMID: 34971883, DOI: 10.1016/j.oraloncology.2021.105694.
- Jacobs D, Breen CT, Pucar D, Holt E, Judson BL, Mehra S. Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer. Thyroid 2020, 31: 272-279. PMID: 32811347, DOI: 10.1089/thy.2020.0237.
- Hanna J, Morse E, Brauer PR, Judson B, Mehra S. Positive margin rates and predictors in transoral robotic surgery after federal approval: A national quality study. Head & Neck 2019, 41: 3064-3072. PMID: 31058417, DOI: 10.1002/hed.25792.
- Li H, Torabi SJ, Park HS, Yarbrough WG, Mehra S, Choi R, Judson BL. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption. The Laryngoscope 2018, 129: 1844-1855. PMID: 30575965, DOI: 10.1002/lary.27740.
- Morse E, Henderson C, Carafeno T, Dibble J, Longley P, Chan E, Judson B, Yarbrough WG, Sasaki C, Mehra S. A Clinical Care Pathway to Reduce ICU Usage in Head and Neck Microvascular Reconstruction. Otolaryngology 2018, 160: 783-790. PMID: 30060705, DOI: 10.1177/0194599818782404.
- Morse E, Judson B, Husain Z, Burtness B, Yarbrough WG, Sasaki C, Cheraghlou S, Mehra S. Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival Associations. Otolaryngology 2018, 159: 987-997. PMID: 30060700, DOI: 10.1177/0194599818779052.
- Shah R, Wilkins S, Safranek C, Shah H, Brophy C, Mehra S. Detection, Patterns, and Outcomes of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngology - Head & Neck Surgery 2024, 150 PMID: 39418066, PMCID: PMC11581730, DOI: 10.1001/jamaoto.2024.3237.
- Dower J, MacLeod R, Cardoso B, Matouk C, Mehra S, Riccio G, Williams L, Majumdar S. 6645 Paraganglioma or Benign Ectopic Thyroid Tissue? Journal Of The Endocrine Society 2024, 8: bvae163.2032. PMCID: PMC11454000, DOI: 10.1210/jendso/bvae163.2032.
- Susan S, Gorman L, Santore E, Boldikova D, Ibrahim G, Kravchenko D, Khan M, Johnson D, Mehra S, Laskin W, Eskendri J. A Rare Pediatric Mandibular Mass: Diagnosis, Treatment and Reconstruction: A Case Report. Oral Surgery Oral Medicine Oral Pathology And Oral Radiology 2024, 138: e63. DOI: 10.1016/j.oooo.2024.04.096.
- Fereydooni S, Valdez C, William L, Malik D, Mehra S, Judson B. Predisposing, Enabling, and Need Factors Driving Palliative Care Use in Head and Neck Cancer. Otolaryngology 2024, 171: 1069-1082. PMID: 38796734, DOI: 10.1002/ohn.819.
- Mehra S. Re: “Prophylactic Intraoperative Antibiotic Dosing in Head and Neck Surgery: Opportunities for Improvement and Future Study”. Otolaryngology 2024, 171: 310-310. PMID: 38606625, DOI: 10.1002/ohn.768.
- Malik D, Jacobs D, Fereydooni S, Park H, Mehra S. Patterns of Care for T1 Glottic Squamous Cell Carcinomas from 2004–2020. The Laryngoscope 2024, 134: 3633-3644. PMID: 38411338, DOI: 10.1002/lary.31363.
- Filley G, Kayastha D, Hayes W, Mehra S, Sherman J, Eckelman M. Environmental Impact of a Direct Laryngoscopy: Opportunities for Pollution Mitigation. The Laryngoscope 2024, 134: 3206-3214. PMID: 38379176, DOI: 10.1002/lary.31341.
- Wilkins S, Shah R, Safranek C, Shah H, Mehra S. The Impact of Four Smoking Metrics on Survival After Diagnosis with HPV+ Oropharyngeal Cancer. The Laryngoscope 2024, 134: 3158-3164. PMID: 38294283, DOI: 10.1002/lary.31319.
- Safranek C, Wilkins S, Shah R, Mehra S. Automated AJCC Restaging for Oropharyngeal Cancer Research. Otolaryngology 2023, 170: 627-629. PMID: 37855637, DOI: 10.1002/ohn.558.
- Avery E, Joshi K, Mehra S, Mahajan A. Role of PET/CT in Oropharyngeal Cancers. Cancers 2023, 15: 2651. PMID: 37174116, PMCID: PMC10177278, DOI: 10.3390/cancers15092651.
- Shah H, Salehi P, Torabi S, Bourdillon A, Wu K, Mehra S. Trends in Private Equity Acquisitions of US Otolaryngology Practices. Otolaryngology 2023, 169: 1094-1097. PMID: 37003295, DOI: 10.1002/ohn.342.
- Salahuddin S, Cohen O, Wu M, Irizarry J, Vega T, Gan G, Deng Y, Isaeva N, Prasad M, Schalper K, Mehra S, Yarbrough W, Emu B. Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer. Clinical Infectious Diseases 2022, 76: 1449-1458. PMID: 36520995, PMCID: PMC10319962, DOI: 10.1093/cid/ciac924.
- Belzer A, Silber A, Mehra S, Gilani S, Leventhal JS. Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T‐DM1). British Journal Of Dermatology 2022, 187: e168-e168. PMID: 35633104, DOI: 10.1111/bjd.21654.
- Shah R, Cohen O, Panth N, Dibble J, Paolillo D, Cook A, Mehra S. Prophylactic Intraoperative Antibiotic Dosing in Head and Neck Surgery: Opportunities for Improvement and Future Study. Otolaryngology 2022, 169: 482-488. PMID: 36113029, DOI: 10.1177/01945998221126144.
- Salahuddin S, Cohen O, Wu M, Irizarry J, Vega T, Gan G, Deng Y, Isaeva N, Schalper K, Mehra S, Yarbrough W, Emu B. Impact of HIV infection on clinical outcomes among people diagnosed with head and neck cancer. Journal Of Clinical Oncology 2022, 40: e18080-e18080. DOI: 10.1200/jco.2022.40.16_suppl.e18080.
- Benchetrit L, Mehra S, Mahajan A, Rahmati RW, Judson BL, Edwards HA. Major Salivary Gland Cancer With Distant Metastasis Upon Presentation: Patterns, Outcomes, and Imaging Implications. Otolaryngology 2021, 167: 305-315. PMID: 34784258, DOI: 10.1177/01945998211058354.
- Yu J, Tsay C, Sasaki C, Son YH, Decker RH, Mehra S, Burtness B. Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs. Oral Oncology 2021, 122: 105585. PMID: 34688055, DOI: 10.1016/j.oraloncology.2021.105585.
- Cohen O, Morse E, Fujiwara RJT, Dibble J, Pierce M, Mehra S. The impact of a double vein anastomoses on doppler's loss of signal rates. European Journal Of Surgical Oncology 2021, 48: 27-31. PMID: 34610861, DOI: 10.1016/j.ejso.2021.09.021.
- Breen CT, Chao J, Mehra S, Kohli N. Extranodal Head and Neck Mantle Cell Lymphoma: Characteristics, Treatment, and Survival. Annals Of Otology Rhinology & Laryngology 2021, 131: 412-419. PMID: 34137303, DOI: 10.1177/00034894211025171.
- Torabi SJ, Kasle DA, Su-Velez B, Mehra S, Day TA, Yarbrough WG, St. John M, Judson BL. A 2020 Update on Public Awareness of Head and Neck Cancers. Otolaryngology 2021, 166: 305-312. PMID: 33845657, DOI: 10.1177/01945998211006932.
- Bourdillon AT, Mehra S, Rahmati R, Judson B, Edwards HA. Anesthesia screen use may impact operating room communication practices in otolaryngology. American Journal Of Otolaryngology 2021, 42: 103000. PMID: 33812208, DOI: 10.1016/j.amjoto.2021.103000.
- Bellamkonda KS, Fereydooni A, Trott K, Lee Y, Mehra S, Nassiri N. Superselective intranidal delivery of platinum-based high-density packing coils for treatment of arteriovenous malformations. Journal Of Vascular Surgery Cases And Innovative Techniques 2021, 7: 230-234. PMID: 33997560, PMCID: PMC8095044, DOI: 10.1016/j.jvscit.2021.01.005.
- Jacobs D, Kafle S, Earles J, Rahmati R, Mehra S, Judson BL. Prolonged inpatient stay after upfront total laryngectomy is associated with overall survival. Laryngoscope Investigative Otolaryngology 2021, 6: 94-102. PMID: 33614936, PMCID: PMC7883619, DOI: 10.1002/lio2.441.
- Izreig S, Alzahrani F, Earles J, Mehra S, Judson BL, Pan Z, Rahmati RW. Hyperprogression of a Sinonasal Squamous Cell Carcinoma Following Programmed Cell Death Protein-1 Checkpoint Blockade. JAMA Otolaryngology - Head & Neck Surgery 2020, 146: 1176-1178. PMID: 32940637, DOI: 10.1001/jamaoto.2020.2584.
- Jacobs D, Torabi SJ, Park HS, Rahmati R, Young MR, Mehra S, Judson BL. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer. Otolaryngology 2020, 164: 1240-1248. PMID: 33198564, DOI: 10.1177/0194599820969613.
- Izreig S, Hajek M, Edwards HA, Mehra S, Sasaki C, Judson BL, Rahmati RW. The role of vitamin D in head and neck cancer. Laryngoscope Investigative Otolaryngology 2020, 5: 1079-1088. PMID: 33364397, PMCID: PMC7752058, DOI: 10.1002/lio2.469.
- JIANG R, MARQUEZ J, TOWER JI, JACOBS D, CHEN W, MEHRA S, PRASAD ML, JUDSON BL. Sequencing of Sclerosing Microcystic Adenocarcinoma Identifies Mutational Burden and Somatic Variants Associated With Tumorigenesis. Anticancer Research 2020, 40: 6375-6379. PMID: 33109575, DOI: 10.21873/anticanres.14658.
- Morse E, Salehi PP, Mehra S. Re: “Value of Intensive Care Unit-Based Postoperative Management for Microvascular Free Flap Reconstruction in Head and Neck Surgery” by Yalamanchi et al. Facial Plastic Surgery & Aesthetic Medicine 2020, 23: 151-151. PMID: 32845717, DOI: 10.1089/fpsam.2020.0403.
- Torabi SJ, Bourdillon A, Salehi PP, Kafle S, Mehra S, Rahmati R, Judson BL. The epidemiology, surgical management, and impact of margins in skull and mandibular osseous‐site tumors. Head & Neck 2020, 42: 3352-3363. PMID: 32743892, DOI: 10.1002/hed.26389.
- Breen CT, Mehra S. An Analysis of Otolaryngology Medical Malpractice Payments From the National Practitioner Data Bank. Otolaryngology 2020, 164: 589-594. PMID: 32691675, DOI: 10.1177/0194599820942498.
- Jacobs D, Torabi SJ, Gibson C, Rahmati R, Mehra S, Judson BL. Assessing National Utilization Trends and Outcomes of Robotic and Endoscopic Thyroidectomy in the United States. Otolaryngology 2020, 163: 947-955. PMID: 32539533, DOI: 10.1177/0194599820927699.
- Jacobs D, Park H, Young M, Olino K, Rahmati R, Mehra S, Burtness B, Judson B. Assessment of Lymph Node Evaluation in Patients with Clinically Node Negative Merkel Cell Carcinoma of the Head and Neck. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1191-1192. DOI: 10.1016/j.ijrobp.2019.11.099.
- Jacobs D, Park H, Young M, Breen C, Rahmati R, Mehra S, Judson B. An Update on Trends and Disparities in Utilization of Total Laryngectomy: a Population-Based Analysis. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1145-1146. DOI: 10.1016/j.ijrobp.2019.11.214.
- Jacobs D, Park H, Rahmati R, Mehra S, Judson B. Changing Demographics of Laryngeal Cancer: Are Patients Getting Younger? International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1162-1163. DOI: 10.1016/j.ijrobp.2019.11.186.
- Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancerSaeed NA, Kelly JR, Deshpande HA, Bhatia AK, Burtness BA, Judson BL, Mehra S, Edwards HA, Yarbrough WG, Peter PR, Holt EH, Decker RH, Husain ZA, Park HS. Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer. Head & Neck 2020, 42: 1031-1044. PMID: 32011055, DOI: 10.1002/hed.26086.
- Yu J, Tsay C, Sasaki C, Son Y, Decker R, Mehra S, Burtness B. 1127P Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs. Annals Of Oncology 2019, 30: v457. DOI: 10.1093/annonc/mdz252.019.
- Husain Z, Lee N, Eskander A, Park H, mehra S, Burtness B. 1149P Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment. Annals Of Oncology 2019, 30: v466. DOI: 10.1093/annonc/mdz252.041.
- Morse E, Hanna J, Mehra S. The Association between Industry Payments and Brand‐Name Prescriptions in Otolaryngologists. Otolaryngology 2019, 161: 605-612. PMID: 31547772, DOI: 10.1177/0194599819852321.
- Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant TherapyLOGANADANE G, KANN BH, PARK HS, JOHNSON SB, MEHRA S, JUDSON BL, BHATIA A, BELKACEMI Y, YARBROUGH WG, BURTNESS B, HUSAIN ZA. Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy. Anticancer Research 2019, 39: 4885-4890. PMID: 31519591, DOI: 10.21873/anticanres.13674.
- Hanna J, Brauer PR, Morse E, Mehra S. Margins in Laryngeal Squamous Cell Carcinoma Treated with Transoral Laser Microsurgery: A National Database Study. Otolaryngology 2019, 161: 986-992. PMID: 31476984, DOI: 10.1177/0194599819874315.
- Clinical Outcomes of Head and Neck Cancer Patients who Undergo Resection, but Forgo Adjuvant TherapyLoganadane G, Kann B, Park H, Johnson S, Mehra S, Judson B, Bhatia A, Belkacemi Y, Yarbrough W, Burtness B, Husain Z. Clinical Outcomes of Head and Neck Cancer Patients who Undergo Resection, but Forgo Adjuvant Therapy. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e375-e376. DOI: 10.1016/j.ijrobp.2019.06.1628.
- Benchetrit L, Torabi SJ, Morse E, Mehra S, Rahmati R, Osborn HA, Judson BL. Preoperative biopsy in parotid malignancies: Variation in use and impact on surgical margins. The Laryngoscope 2019, 130: 1450-1458. PMID: 31411749, DOI: 10.1002/lary.28224.
- Hanna J, Brauer PR, Morse E, Berson E, Mehra S. Epidemiological analysis of croup in the emergency department using two national datasets. International Journal Of Pediatric Otorhinolaryngology 2019, 126: 109641. PMID: 31442871, DOI: 10.1016/j.ijporl.2019.109641.
- Hanna J, Brauer PR, Morse E, Judson B, Mehra S. Is robotic surgery an option for early T‐stage laryngeal cancer? Early nationwide results. The Laryngoscope 2019, 130: 1195-1201. PMID: 31233223, DOI: 10.1002/lary.28144.
- Benchetrit L, Morse E, Judson BL, Mehra S. Positive Surgical Margins in Submandibular Malignancies: Facility and Practice Variation. Otolaryngology 2019, 161: 620-628. PMID: 31159649, DOI: 10.1177/0194599819852094.
- Lee NCJ, Eskander A, Park HS, Mehra S, Burtness BA, Husain Z. Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment. Cancer 2019, 125: 2975-2983. PMID: 31090934, DOI: 10.1002/cncr.32161.
- Benchetrit L, Torabi SJ, Tate JP, Mehra S, Osborn HA, Young MR, Burtness B, Judson BL. Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment. Oral Oncology 2019, 94: 32-40. PMID: 31178210, DOI: 10.1016/j.oraloncology.2019.05.009.
- Brauer PR, Morse E, Mehra S. Industry Payments for Otolaryngology Research: A Four‐Year Analysis of the Open Payments Database. The Laryngoscope 2019, 130: 314-320. PMID: 31059584, DOI: 10.1002/lary.27896.
- Miccio J, Kelly J, Kann B, An Y, Park H, Verma V, Mehra S, Judson B, Burtness B, Husain Z. OA01 Impact of Contralateral Lymph Node Involvement on Survival of Surgically-Managed HPV-Positive Oropharyngeal Cancer Staged with the AJCC Eighth Edition. International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e1. DOI: 10.1016/s0360-3016(19)30402-x.
- Morse E, Berson E, Mehra S. Industry Involvement in Otolaryngology: Updates from the 2017 Open Payments Database. Otolaryngology 2019, 161: 265-270. PMID: 30909808, DOI: 10.1177/0194599819838268.
- Hanna J, Brauer PR, Berson E, Mehra S. Adult epiglottitis: Trends and predictors of mortality in over 30 thousand cases from 2007 to 2014. The Laryngoscope 2018, 129: 1107-1112. PMID: 30582183, DOI: 10.1002/lary.27741.
- Mehra S, Fujiwara R. In Response to Accuracy and Reliability of the Flow Coupler in Postoperative Monitoring of Head and Neck Free Flaps. The Laryngoscope 2018, 129: e8-e8. PMID: 30499110, DOI: 10.1002/lary.27332.
- Savoca E, Mehra S, Waldman EH. A case of pediatric cervicofacial actinomyces masquerading as malignancy: Case report and review of the literature. International Journal Of Pediatric Otorhinolaryngology 2018, 116: 204-208. PMID: 30554700, DOI: 10.1016/j.ijporl.2018.11.001.
- Morse E, Berson E, Fujiwara R, Judson B, Mehra S. Hypopharyngeal Cancer Treatment Delays: Benchmarks and Survival Association. Otolaryngology 2018, 160: 267-276. PMID: 30324861, DOI: 10.1177/0194599818797605.
- Morse E, Fujiwara RJT, Mehra S. Industry Payments to Physicians and Prescriptions of Brand‐Name Proton‐Pump Inhibitors. Otolaryngology 2018, 160: 70-76. PMID: 30325706, DOI: 10.1177/0194599818803337.
- Delgado S, Smith SM, Mehra S, Prasad ML. Composite Paraganglioma: Pioneering in the Head and Neck. International Journal Of Surgical Pathology 2018, 27: 282-289. PMID: 30222023, DOI: 10.1177/1066896918799940.
- Morse E, Fujiwara RJT, Judson B, Prasad ML, Mehra S. Positive surgical margins in parotid malignancies: Institutional variation and survival association. The Laryngoscope 2018, 129: 129-137. PMID: 30194762, DOI: 10.1002/lary.27221.
- Cheraghlou S, Schettino A, Zogg CK, Otremba MD, Bhatia A, Park HS, Osborn HA, Mehra S, Yarbrough WG, Judson BL. Adjuvant Chemotherapy Is Associated With Improved Survival for Late‐Stage Salivary Squamous Cell Carcinoma. The Laryngoscope 2018, 129: 883-889. PMID: 30151947, DOI: 10.1002/lary.27444.
- Cheraghlou S, Torabi SJ, Husain ZA, Otremba MD, Osborn HA, Mehra S, Yarbrough WG, Burtness BA, Judson BL. HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes. The Laryngoscope 2018, 129: 684-691. PMID: 30151832, DOI: 10.1002/lary.27475.
- Cheraghlou S, Yu PK, Otremba MD, Mehra S, Yarbrough WG, Judson BL. Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glands. Cancers Of The Head & Neck 2018, 3: 5. PMID: 31093358, PMCID: PMC6460801, DOI: 10.1186/s41199-018-0032-x.
- Morse E, Fujiwara RJT, Mehra S. The Association of Industry Payments to Physicians with Prescription of Brand‐Name Intranasal Corticosteroids. Otolaryngology 2018, 159: 442-448. PMID: 29865931, DOI: 10.1177/0194599818774739.
- Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall SurvivalLi H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. JAMA Otolaryngology - Head & Neck Surgery 2018, 144: 519-525. PMID: 29801040, PMCID: PMC6583856, DOI: 10.1001/jamaoto.2018.0395.
- Morse E, Fujiwara RJT, Mehra S. Increasing Industry Involvement in Otolaryngology: Insights from 3 Years of the Open Payments Database. Otolaryngology 2018, 159: 501-507. PMID: 29807484, DOI: 10.1177/0194599818778502.
- Morse E, Judson B, Husain Z, Burtness B, Yarbrough W, Sasaki C, Cheraghlou S, Mehra S. National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiation. Oral Oncology 2018, 82: 122-130. PMID: 29909886, DOI: 10.1016/j.oraloncology.2018.02.010.
- Morse E, Fujiwara RJT, Judson B, Mehra S. Treatment delays in laryngeal squamous cell carcinoma: A national cancer database analysis. The Laryngoscope 2018, 128: 2751-2758. PMID: 29756382, DOI: 10.1002/lary.27247.
- Cheraghlou S, Kuo P, Mehra S, Agogo GO, Bhatia A, Husain ZA, Yarbrough WG, Burtness BA, Judson BL. Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database. Head & Neck 2018, 40: 1343-1355. PMID: 29756412, DOI: 10.1002/hed.24984.
- Morse E, Fujiwara RJT, Husain Z, Judson B, Mehra S. Pediatric Salivary Cancer: Epidemiology, Treatment Trends, and Association of Treatment Modality with Survival. Otolaryngology 2018, 159: 553-563. PMID: 29688836, DOI: 10.1177/0194599818771926.
- Kelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer. Oral Oncology 2018, 79: 64-70. PMID: 29598952, DOI: 10.1016/j.oraloncology.2018.02.017.
- Morse E, Fujiwara RJT, Judson B, Mehra S. Treatment Times in Salivary Gland Cancer: National Patterns and Association with Survival. Otolaryngology 2018, 159: 283-292. PMID: 29460669, DOI: 10.1177/0194599818758020.
- Pathak N, Fujiwara RJT, Mehra S. Assessment of Nonresearch Industry Payments to Otolaryngologists in 2014 and 2015. Otolaryngology 2018, 158: 1028-1034. PMID: 29437524, DOI: 10.1177/0194599818758661.
- Cheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL. Salvage Surgery after Radiation Failure in T1/T2 Larynx Cancer: Outcomes following Total versus Conservation Surgery. Otolaryngology 2018, 158: 497-504. PMID: 29292665, DOI: 10.1177/0194599817742596.
- Cheraghlou S, Yu PK, Otremba MD, Park HS, Bhatia A, Zogg CK, Mehra S, Yarbrough WG, Judson BL. Treatment deintensification in human papillomavirus‐positive oropharynx cancer: Outcomes from the National Cancer Data Base. Cancer 2017, 124: 717-726. PMID: 29243245, DOI: 10.1002/cncr.31104.
- Biktasova A, Hajek M, Sewell A, Gary C, Bellinger G, Deshpande HA, Bhatia A, Burtness B, Judson B, Mehra S, Yarbrough WG, Issaeva N. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus–Associated Head and Neck Cancer. Clinical Cancer Research 2017, 23: 7276-7287. PMID: 28916527, DOI: 10.1158/1078-0432.ccr-17-1438.
- Outcomes and reliability of the flow coupler in postoperative monitoring of head and neck free flapsFujiwara RJT, Dibble JM, Larson SV, Pierce ML, Mehra S. Outcomes and reliability of the flow coupler in postoperative monitoring of head and neck free flaps. The Laryngoscope 2017, 128: 812-817. PMID: 28988465, DOI: 10.1002/lary.26944.
- Fujiwara RJT, Shih AF, Mehra S. Cross‐sectional Analysis of the Relationship between Paranasal Sinus Balloon Catheter Dilations and Industry Payments among Otolaryngologists. Otolaryngology 2017, 157: 880-886. PMID: 28895455, DOI: 10.1177/0194599817728897.
- Cheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL. Untreated oral cavity cancer: Long‐term survival and factors associated with treatment refusal. The Laryngoscope 2017, 128: 664-669. PMID: 28865100, DOI: 10.1002/lary.26809.
- Fujiwara RJT, Burtness B, Husain ZA, Judson BL, Bhatia A, Sasaki CT, Yarbrough WG, Mehra S. Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatment. Oral Oncology 2017, 71: 129-137. PMID: 28688680, DOI: 10.1016/j.oraloncology.2017.06.013.
- Husain ZA, Chen T, Corso CD, Wang Z, Park H, Judson B, Yarbrough W, Deshpande H, Mehra S, Kuo P, Decker RH, Burtness BA. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma. JAMA Oncology 2017, 3: 358-365. PMID: 27737449, DOI: 10.1001/jamaoncol.2016.4581.
- Fujiwara RJ, Judson BL, Yarbrough WG, Husain Z, Mehra S. Treatment delays in oral cavity squamous cell carcinoma and association with survival. Head & Neck 2017, 39: 639-646. PMID: 28236349, DOI: 10.1002/hed.24608.
- Kuo P, Mehra S, Sosa JA, Roman SA, Husain ZA, Burtness BA, Tate JP, Yarbrough WG, Judson BL. Proposing prognostic thresholds for lymph node yield in clinically lymph node‐negative and lymph node‐positive cancers of the oral cavity. Cancer 2016, 122: 3624-3631. PMID: 27479645, DOI: 10.1002/cncr.30227.
- Subramanian HE, Park HS, Barbieri A, Mahajan A, Judson BL, Mehra S, Yarbrough WG, Burtness BA, Husain ZA. Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study. Cancers Of The Head & Neck 2016, 1: 7. PMID: 31093337, PMCID: PMC6460847, DOI: 10.1186/s41199-016-0008-7.
- Panaccione A, Chang MT, Carbone BE, Guo Y, Moskaluk CA, Virk RK, Chiriboga L, Prasad ML, Judson B, Mehra S, Yarbrough WG, Ivanov SV. NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic Carcinoma. Clinical Cancer Research 2016, 22: 2083-2095. PMID: 27084744, PMCID: PMC4834904, DOI: 10.1158/1078-0432.ccr-15-2208.
- Kuo P, Sosa JA, Burtness BA, Husain ZA, Mehra S, Roman SA, Yarbrough WG, Judson BL. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base. Cancer 2016, 122: 1853-1860. PMID: 27019213, DOI: 10.1002/cncr.29962.
- Haser GC, Tuttle RM, Su HK, Alon EE, Bergman D, Bernet V, Brett E, Cobin R, Dewey EH, Doherty G, Dos Reis LL, Harris J, Klopper J, Lee SL, Levine RA, Lepore SJ, Likhterov I, Lupo MA, Machac J, Mechanick JI, Mehra S, Milas M, Orloff LA, Randolph G, Revenson TA, Roberts KJ, Ross DS, Rowe ME, Smallridge RC, Terris D, Tufano RP, Urken ML. Active Surveillance for Papillary Thyroid Microcarcinoma: New Challenges and Opportunities for The Health Care System. Endocrine Practice 2016, 22: 602-611. PMID: 26799628, PMCID: PMC5539410, DOI: 10.4158/ep151065.ra.
- Rowe ME, Clain JB, Scherl S, Dos Reis L, Turk A, Wenig BM, Mehra S, Urken ML. Response to “Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology”. European Journal Of Surgical Oncology 2015, 42: 156-157. PMID: 26632081, DOI: 10.1016/j.ejso.2015.09.029.
- Castro J, Likhterov I, Mehra S, Bassiri-Tehrani M, Scherl S, Clain J, Buchbinder D, Urken ML. Approach to en bloc resection and reconstruction of primary masticator space malignancies. The Laryngoscope 2015, 126: 372-377. PMID: 26526821, DOI: 10.1002/lary.25500.
- Schwam ZG, Burtness B, Yarbrough WG, Mehra S, Husain Z, Judson BL. National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database. Cancer Medicine 2015, 4: 1828-1835. PMID: 26471244, PMCID: PMC5123708, DOI: 10.1002/cam4.546.
- Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Hospital readmission and 30‐day mortality after surgery for oral cavity cancer: Analysis of 21,681 cases. Head & Neck 2015, 38: e221-e226. PMID: 25537226, DOI: 10.1002/hed.23973.
- Azar M, Folk D, Henderson T, Mehra S, Vining E, Banach D. Cervicofacial necrotizing fasciitis caused by Haemophilus influenzae serotype e in a patient with Sjogren's syndrome, systemic lupus erythematosus and hypocomplementaemia. JMM Case Reports 2015, 2 DOI: 10.1099/jmmcr.0.000040.
- Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base. JAMA Otolaryngology - Head & Neck Surgery 2015, 141: 593-598. PMID: 25974757, DOI: 10.1001/jamaoto.2015.0719.
- Rathi VK, Ross JS, Samuel AM, Mehra S. Postmarket Modifications of High‐Risk Therapeutic Devices in Otolaryngology Cleared by the US Food and Drug Administration. Otolaryngology 2015, 153: 400-408. PMID: 26044785, DOI: 10.1177/0194599815587508.
- Tewari A, Blumberg J, Mehra S. An Infratemporal Fossa Mass. JAMA Otolaryngology - Head & Neck Surgery 2015, 141: 575-576. PMID: 25880880, DOI: 10.1001/jamaoto.2015.0517.
- Temporoparietal fascia flap “sandwich” technique for repair of near‐total traumatic auricle avulsionKong DK, Schutt CA, Mehra S. Temporoparietal fascia flap “sandwich” technique for repair of near‐total traumatic auricle avulsion. The Laryngoscope 2015, 126: 826-828. PMID: 26014884, DOI: 10.1002/lary.25394.
- Rathi VK, Samuel AM, Mehra S. Industry Ties in Otolaryngology. Otolaryngology 2015, 152: 993-999. PMID: 25779469, DOI: 10.1177/0194599815573718.
- Mehra S, Tuttle RM, Milas M, Orloff L, Bergman D, Bernet V, Brett E, Cobin R, Doherty G, Judson BL, Klopper J, Lee S, Lupo M, Machac J, Mechanick JI, Randolph G, Ross DS, Smallridge R, Terris D, Tufano R, Alon E, Clain J, DosReis L, Scherl S, Urken ML. Database and Registry Research in Thyroid Cancer: Striving for a New and Improved National Thyroid Cancer Database. Thyroid 2015, 25: 157-168. PMID: 25517683, DOI: 10.1089/thy.2014.0270.
- Mehra S, Jacobson A, Urken M. Free Tissue for Reconstruction of the Bony Facial Skeleton. 2014, 633-670. DOI: 10.1201/b17991-35.
- Scherl S, Mehra S, Clain J, Dos Reis L, Persky M, Turk A, Weing B, Husaini H, Urken M. The Effect of Surgeon Experience on the Detection of Metastatic Lymph Nodes in the Central Compartment and the Pathologic Features of Clinically Unapparent Metastatic Lymph Nodes: What Are We Missing When We Don't Perform a Prophylactic Dissection of Central Compartment Lymph Nodes in Papillary Thyroid Cancer? VideoEndocrinology 2014, 1 DOI: 10.1089/ve.2014.0022.
- Clain JB, Mehra S, Scherl S, Dos Reis LL, Turk A, Wenig BM, Dewey EH, Urken ML. Intrathyroidal Tumors Presenting with Extranodal Extension: What Are We Missing? Endocrine Pathology 2014, 25: 385-389. PMID: 25325929, DOI: 10.1007/s12022-014-9340-9.
- Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Positive Surgical Margins in Early Stage Oral Cavity Cancer: An Analysis of 20,602 Cases. Otolaryngology 2014, 151: 984-990. PMID: 25257901, DOI: 10.1177/0194599814551718.
- Dos Reis LL, Tuttle RM, Alon E, Bergman DA, Bernet V, Brett EM, Cobin R, Doherty G, Harris JR, Klopper J, Lee SL, Lupo M, Milas M, Machac J, Mechanick JI, Orloff L, Randolph G, Ross DS, Smallridge RC, Terris DJ, Tufano RP, Mehra S, Scherl S, Clain JB, Urken ML. What Is the Gold Standard for Comprehensive Interinstitutional Communication of Perioperative Information for Thyroid Cancer Patients? A Comparison of Existing Electronic Health Records with the Current American Thyroid Association Recommendations. Thyroid 2014, 24: 1466-1472. PMID: 25036190, DOI: 10.1089/thy.2014.0209.
- Aronberg RM, Punekar SR, Adam SI, Judson BL, Mehra S, Yarbrough WG. Esophageal perforation caused by edible foreign bodies: A systematic review of the literature. The Laryngoscope 2014, 125: 371-378. PMID: 25155167, DOI: 10.1002/lary.24899.
- Dos Reis LL, Mehra S, Scherl S, Clain J, Machac J, Urken ML. The Differential Diagnosis of Central Compartment Radioactive Iodine Uptake After Thyroidectomy: Anatomic and Surgical Considerations. Endocrine Practice 2014, 20: 832-838. PMID: 24793917, DOI: 10.4158/ep13435.ra.
- Gibber MJ, Clain JB, Jacobson AS, Buchbinder D, Scherl S, Zevallos JP, Mehra S, Urken ML. Subscapular system of flaps: An 8‐year experience with 105 patients. Head & Neck 2014, 37: 1200-1206. PMID: 24800735, DOI: 10.1002/hed.23738.
- Dibelius G, Mehra S, Clain JB, Urken ML, Wenig BM. Noninvasive Anaplastic Thyroid Carcinoma: Report of a Case and Literature Review. Thyroid 2014, 24: 1319-1324. PMID: 24865498, DOI: 10.1089/thy.2013.0586.
- Scherl S, Mehra S, Clain J, Dos Reis LL, Persky M, Turk A, Wenig B, Husaini H, Urken ML. The Effect of Surgeon Experience on the Detection of Metastatic Lymph Nodes in the Central Compartment and the Pathologic Features of Clinically Unapparent Metastatic Lymph Nodes: What Are We Missing When We Don't Perform a Prophylactic Dissection of Central Compartment Lymph Nodes in Papillary Thyroid Cancer? Thyroid 2014, 24: 1282-1288. PMID: 24787362, DOI: 10.1089/thy.2013.0600.
- Clain JB, Scherl S, Dos Reis L, Turk A, Wenig BM, Mehra S, Karle WE, Urken ML. Extrathyroidal Extension Predicts Extranodal Extension in Patients with Positive Lymph Nodes: An Important Association That May Affect Clinical Management. Thyroid 2014, 24: 951-957. PMID: 24443878, DOI: 10.1089/thy.2013.0557.
- Mehra S, Scherl S, Lazarus C, Dewey E, Urken ML. Transtracheal approach to repair of a tracheo‐colonic fistula 44 years after colonic interposition. Head & Neck 2014, 36: e117-e120. PMID: 24375707, DOI: 10.1002/hed.23586.
- Mehra S, Tuttle RM, Bergman D, Bernet V, Brett E, Cobin R, Doherty G, Klopper J, Lee S, Machac J, Milas M, Mechanick JI, Orloff L, Randolph G, Ross DS, Smallridge R, Terris D, Tufano R, Alon E, Clain J, Dos Reis L, Scherl S, Urken ML. Improving the Quality of Thyroid Cancer Care: How Does the Thyroid Cancer Care Collaborative Cross the Institute of Medicine's Quality Chasm? Thyroid 2014, 24: 615-624. PMID: 24512449, DOI: 10.1089/thy.2013.0441.
- Mehra S, Heineman TE, Cammisa FP, Girardi FP, Sama AA, Kutler DI. Factors Predictive of Voice and Swallowing Outcomes after Anterior Approaches to the Cervical Spine. Otolaryngology 2013, 150: 259-265. PMID: 24367048, DOI: 10.1177/0194599813515414.
- Mehra S, Liu J, Gupta A, Sheinfeld J, Kraus D. Cervical metastasis of germ cell tumors: Evaluation, management, complications, and outcomes. The Laryngoscope 2012, 122: 286-290. PMID: 22252920, DOI: 10.1002/lary.22422.
- Morris LG, Mehra S, Shah JP, Bilsky MH, Selesnick SH, Kraus DH. Predictors of survival and recurrence after temporal bone resection for cancer. Head & Neck 2011, 34: 1231-1239. PMID: 21953902, PMCID: PMC4126564, DOI: 10.1002/hed.21883.
- Mehra S, Morris L, Shah J, Bilsky M, Selesnick S, Kraus D. Outcomes of Temporal Bone Resection for Locally Advanced Parotid Cancer. Journal Of Neurological Surgery Part B Skull Base 2011, 21: 389-396. PMID: 22547966, PMCID: PMC3312127, DOI: 10.1055/s-0031-1287682.
- Mehra S, Chang C, Kacker A. Isolated Sarcoidosis of the Tonsil: Case Report and Literature Review. The Laryngoscope 2011, 121: s79-s79. DOI: 10.1002/lary.21949.
- Mehra S, Morris L, Shah J, Bilsky M, Selesnick S, Kraus D. Outcomes of Temporal Bone Resection for Locally Advanced Parotid Cancer. Journal Of Neurological Surgery Part B Skull Base 2011, 21 DOI: 10.1055/s-2011-1274336.
- Morris L, Mehra S, Shah J, Bilsky M, Selesnick S, Kraus D. Predictors of Survival and Recurrence after Temporal Bone Resection for Cancer. Journal Of Neurological Surgery Part B Skull Base 2011, 21 DOI: 10.1055/s-2011-1274337.
- Nyquist GG, Anand VK, Mehra S, Kacker A, Schwartz TH. Endoscopic endonasal repair of anterior skull base non-traumatic cerebrospinal fluid leaks, meningoceles, and encephaloceles. Journal Of Neurosurgery 2009, 113: 961-6. PMID: 19929192, DOI: 10.3171/2009.10.jns08986.
- Nyquist G, Anand V, Mehra S, Kacker A, Schwartz T. Endoscopic Endonasal Repair of Anterior Skull Base Encephaloceles and Cerebrospinal Fluid Leaks. Journal Of Neurological Surgery Part B Skull Base 2009, 19 DOI: 10.1055/s-2009-1242328.
- Mehra S, Eavey RD, Keamy DG. The epidemiology of hearing impairment in the United States: Newborns, children, and adolescents. Otolaryngology 2009, 140: 461-472. PMID: 19328331, DOI: 10.1016/j.otohns.2008.12.022.
- Smilow Cancer Hospital Head and Neck Cancers ProgramSmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 4New Haven, CT 06511
- Smilow Cancer Hospital Head and Neck Cancers ProgramPark Avenue Medical Center5520 Park AvenueTrumbull, CT 06611
- Smilow Cancer Hospital Head and Neck Cancers ProgramSmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 4New Haven, CT 06511
- Smilow Cancer Hospital Head and Neck Cancers ProgramPark Avenue Medical Center5520 Park AvenueTrumbull, CT 06611